profit from every $100 of sales.
$0$100
LifeStance Health Group
$14.08-0.49% today
+127.1% in 1 year
1-year low $6.181-year high $14.60
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2025.
0%20% a year
You pay $553.98 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What LifeStance Health Group sold, what it kept, and what it did with the cash.
Sales went from $860 million in 2022 to $1.42 billion in 2025, with $9.66 million of profit last year.
SalesProfit
LifeStance Health Group vs. similar companies
LifeStance Health Group grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| LifeStance Health Group | 554.0× · Very expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads LifeStance Health Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 213 | 668 | 860 | 1,056 | 1,251 | 1,424 | |
| – | – | 237 | 302 | 402 | 461 | |
| 15 | -286 | -210 | -189 | -32 | 24 | |
| 19 | -240 | -144 | -105 | 40 | 79 | |
| 6 | -307 | -216 | -186 | -57 | 10 | |
| – | – | -0.61 | -0.51 | -0.15 | 0.02 | |
| – | – | 27.6% | 28.6% | 32.2% | 32.4% | |
| 7.2% | -42.9% | -24.5% | -17.9% | -2.5% | 1.7% | |
| 2.7% | -46.0% | -25.1% | -17.6% | -4.6% | 0.7% |
Balance sheet
| In millions of USD | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | – | 1,927 | 2,174 | 2,110 | 2,118 | 2,204 |
| Cash | 3 | 148 | 109 | 79 | 155 | 249 |
| Total debt | – | 161 | 476 | 511 | 485 | 475 |
| Total liabilities | – | 382 | 655 | 681 | 672 | 683 |
| – | 1,545 | 1,519 | 1,429 | 1,446 | 1,521 | |
| – | 0 | 355 | 367 | 379 | 391 | |
| – | -13.6% | -8.4% | -7.5% | -1.3% | 1.0% | |
| – | -19.9% | -14.2% | -13.0% | -4.0% | 0.6% |
Cash flow
| In millions of USD | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 17 | 9 | 53 | -17 | 107 | 146 | |
| 14 | 94 | 79 | 41 | 22 | 36 | |
| 3 | -85 | -26 | -57 | 86 | 110 | |
| Dividends paid | – | – | – | – | – | – |
| – | – | 0 | – | – | – | |
| 0 | 259 | 187 | 99 | 76 | 75 |
Valuation
- 554.0×
- 192.6×
- –
- 3.3×
- 3.8×
- 48.7×
- 70.8×
- 2.1%
- 0.2%
- 0.0%
Profitability
- 32.4%
- 1.7%
- 0.7%
- 6.6%
- 1.0%
- -4.2%
- 1.6%
- 1.1%
- 2.4%
- –
Growth
- +20.9%
- –
- +28.4%
- –
- +3.3%
Financial health
- 2.9×
- 0.31
- 9.1%
- 2.1×
- 1.65
- 1.48
- 0.70
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 32%of 964
Bottom 25%of 898
Top 25%of 911
Top 46%of 991
What analysts expect
- Average price target
- $9.30
- Range
- $8.00 – $11.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 0.04 | 0.01 | +300.0% |
| Feb 25, 2026 | 0.03 | -0.00 | +3,291.5% |
| Nov 6, 2025 | 0.00 | -0.01 | +127.7% |
| Aug 7, 2025 | -0.01 | -0.03 | +66.7% |
| May 7, 2025 | 0.00 | -0.04 | +104.6% |
| Feb 27, 2025 | -0.02 | -0.04 | +50.0% |
| Nov 7, 2024 | -0.02 | -0.07 | +71.4% |
| Aug 8, 2024 | -0.06 | -0.07 | +14.3% |
News
LifeStance prices $590.4M secondary offering at $13.12 per shareSeeking Alpha · Nov 9, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
29No pass
Benjamin Graham
27No pass
Philip Fisher
35No pass
Peter Lynch
68Pass
Joel Greenblatt
0No pass
Charlie Munger
18No pass
Terry Smith
25No pass
Questions about LifeStance Health Group
Is LifeStance Health Group a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the LifeStance Health Group AI analysis
What does LifeStance Health Group do?
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. It is in Medical Care Facilities, based in Scottsdale, AZ, United States, with 8,349 employees.
Does LifeStance Health Group pay a dividend?
No. LifeStance Health Group does not pay a dividend at the moment.
Is LifeStance Health Group stock halal?
Yes. LifeStance Health Group passes our halal screen: its business is permitted and its debt is 9% of its market value, under the 30% limit. How we check
How has LifeStance Health Group stock done over the past year?
Up 127.1% over the past twelve months, to $14.08. It traded between $6.18 and $14.60 and is 3.6% below its high.
Who are LifeStance Health Group's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with LifeStance Health Group's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.